Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

Clinical trial NCT00513877 · COMPLETED

Trial details

NCT number: NCT00513877
Sponsor: Cancer Trials Ireland
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Mesothelioma

Start date: 2006-05-01
Primary completion: 2009-12-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.